Security key
98420P308
Xtant Medical Holdings, Inc. - Common Stock (XTNT)
CUSIP: 98420P308
Q1 2021 13F Holders as of 31 Mar 2021
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 74,502,096
- Total 13F value
- $175,824,000
- Share change
- +741,731
- SEC-reported price per share
- $2.36
- Number of holders
- 14
- Value change
- +$1,768,228
- Number of buys
- 11
- Number of sells
- 3
- Shares outstanding
- 140,036,400
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2021
Institutions
14
Top holders
10
XTNT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2021
Previous quarter: Q4 2020
Xtant Medical Holdings, Inc. SEC filings
Xtant Medical Holdings, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 98420P308
Recent filing periods:
Ownership snapshot
Top reported holders of XTNT - Xtant Medical Holdings, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ORBIMED ADVISORS LLC
Disclosed value leader
ORBIMED ADVISORS LLC
Comparable rows
12/13
Latest evidence
31 Dec 2020
13F
Lead comparable stake: 52%
1 rows are not safely comparable across share classes.
Showing 1-6 of 13 holder rows.
Quick read
ORBIMED ADVISORS LLC leads the comparable SEC ownership view at 52%.
12 of 13 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ORBIMED ADVISORS LLC's linked filing trail.
Comparable ownership
Top 5
ORBIMED ADVISORS LLC
52%
RENAISSANCE TECHNOLOGIES LLC
0.45%
BRIDGEWAY CAPITAL MANAGEMENT, LLC
0.11%
CITADEL ADVISORS LLC
0.05%
VANGUARD GROUP INC
0.03%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 13 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
Company
|
52%
|
$87,080,000
72,803,072 shares
|
— | 31 Dec 2020 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
0.45%
|
$751,000
627,690 shares
|
— | 31 Dec 2020 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.11%
|
$179,000
150,000 shares
|
— | 31 Dec 2020 |
| CITADEL ADVISORS LLC |
13F
Company
|
0.05%
|
$80,000
67,056 shares
|
— | 31 Dec 2020 |
| VANGUARD GROUP INC |
13F
Company
|
0.03%
|
$53,000
44,170 shares
|
— | 31 Dec 2020 |
| Tower Research Capital LLC (TRC) |
13F
Company
|
0.02%
|
$26,000
21,607 shares
|
— | 31 Dec 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
14
Shares
74,502,096
Rows available
14
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2021 vs Q4 2020 Across Filers
Q4 2020 holders
11
Q1 2021 holders
14
Holder diff
3
| Investor | Q4 2020 Shares | Q1 2021 Shares | Share Diff | Share Chg % | Q4 2020 value | Q1 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend